Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Atrophy rates accelerate in amnestic mild cognitive impairment.

Jack CR Jr, Weigand SD, Shiung MM, Przybelski SA, O'Brien PC, Gunter JL, Knopman DS, Boeve BF, Smith GE, Petersen RC.

Neurology. 2008 May 6;70(19 Pt 2):1740-52. Epub 2007 Nov 21.

2.

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.

Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Neurology. 2008 Feb 12;70(7):512-20. Epub 2007 Sep 26.

3.

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Brain. 2007 Jul;130(Pt 7):1777-86. Epub 2007 May 28.

4.

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC.

Neurology. 2005 Oct 25;65(8):1227-31.

5.

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment.

Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr.

Neurology. 2005 Mar 8;64(5):902-4.

6.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

7.

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):287-93. doi: 10.1212/WNL.0b013e3181af79e5.

8.

Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.

van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; Alzheimer's Disease Cooperative Study Group.

J Neurol. 2008 Sep;255(9):1302-8. doi: 10.1007/s00415-008-0874-y. Epub 2008 Sep 25.

9.

Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin?

Brambati SM, Belleville S, Kergoat MJ, Chayer C, Gauthier S, Joubert S.

Dement Geriatr Cogn Disord. 2009;28(6):541-9. doi: 10.1159/000255240. Epub 2009 Dec 14.

PMID:
20016185
10.

Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, Shaw LM, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Jul 13;75(2):143-51. doi: 10.1212/WNL.0b013e3181e7ca82.

11.

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.

Neurology. 2005 Mar 8;64(5):861-5.

PMID:
15753423
12.

Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer's disease.

Balthazar ML, Yasuda CL, Pereira FR, Pedro T, Damasceno BP, Cendes F.

Eur J Neurol. 2009 Apr;16(4):468-74. doi: 10.1111/j.1468-1331.2008.02408.x.

PMID:
19138329
13.

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.

Neurology. 2007 Oct 9;69(15):1491-7.

PMID:
17923611
14.

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut M, Resnick SM.

Neurology. 2009 Jun 2;72(22):1906-13. doi: 10.1212/WNL.0b013e3181a82634.

15.

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC.

Neurology. 2004 Feb 24;62(4):591-600.

16.

Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.

Zhuang L, Sachdev PS, Trollor JN, Reppermund S, Kochan NA, Brodaty H, Wen W.

PLoS One. 2013;8(3):e58887. doi: 10.1371/journal.pone.0058887. Epub 2013 Mar 14.

17.

Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.

Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H.

Neurology. 2008 Dec 9;71(24):1986-92. doi: 10.1212/01.wnl.0000336925.79704.9f.

18.

Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Mah L, Binns MA, Steffens DC; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2015 May;23(5):466-76. doi: 10.1016/j.jagp.2014.10.005. Epub 2014 Oct 29.

19.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E.

Neurology. 2000 Aug 22;55(4):484-89.

20.

Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.

Kim JH, Hwang KJ, Kim JH, Lee YH, Rhee HY, Park KC.

J Clin Neurosci. 2011 Aug;18(8):1101-6. doi: 10.1016/j.jocn.2011.01.008. Epub 2011 Jul 2.

PMID:
21723730
Items per page

Supplemental Content

Write to the Help Desk